In-depth: New licenses could spark manufacture of COVID-19 pills in Africa

Pharmaceutical companies Merck and Pfizer recently announced early results from clinical trials showing that two new antiviral medicines are highly effective in reducing COVID-19 deaths and hospitalisation. The Medicines Patent Pool then announced licensing deals with both companies that will allow for generic versions of the two drugs to be produced. Catherine Tomlinson unpacks the licenses and asks whether generic versions of these pills might now be made in Africa.

Read More

In-depth: Is government ready to invest in mental health?

Mental health does not have its own ring-fenced budget and given huge inefficiencies in our mental health spending, we need to be strategic on where and how we spend the little we have. Alicestine October unpacks what a new government-commissioned mental health investment case framework can mean for access to equitable and quality mental health services in the country. 

Read More

What public sector mental health services look like in the Free State

A 36-year-old mother living with HIV from Thabong in Welkom in the Free State is among the many millions of people in South Africa who rely on public healthcare services. Also, like many others, the COVID-19 pandemic and its associated disruptions have left her in a constant struggle with anxiety. Refilwe Mochoari asks what mental health services are available to people in the Free State who depend on the public healthcare system.

Read More

Spotlight on Women in Health

In 1947 the first black woman qualified as a doctor in South Africa. Her name was Mary Malahlela-Xakana. It took the country about 60 years after its first black male doctor started practicing for Malahlela-Xakana to don her stethoscope and practice medicine. Much, but not enough has changed since then, writes Alicestine October.

Read More